- Home
- THW vs TRDA Comparison
THW vs TRDA Comparison
Compare THW & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THW
- TRDA
- Stock Information
- Founded
- THW 2015
- TRDA 2016
- Country
- THW United States
- TRDA United States
- Employees
- THW N/A
- TRDA N/A
- Industry
- THW Finance Companies
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- THW Finance
- TRDA Health Care
- Exchange
- THW Nasdaq
- TRDA Nasdaq
- Market Cap
- THW 405.3M
- TRDA 336.6M
- IPO Year
- THW N/A
- TRDA 2021
- Fundamental
- Price
- THW $10.53
- TRDA $8.62
- Analyst Decision
- THW
- TRDA Strong Buy
- Analyst Count
- THW 0
- TRDA 3
- Target Price
- THW N/A
- TRDA $25.67
- AVG Volume (30 Days)
- THW 149.9K
- TRDA 154.3K
- Earning Date
- THW 01-01-0001
- TRDA 05-08-2025
- Dividend Yield
- THW 10.76%
- TRDA N/A
- EPS Growth
- THW N/A
- TRDA N/A
- EPS
- THW N/A
- TRDA 0.61
- Revenue
- THW N/A
- TRDA $172,220,000.00
- Revenue This Year
- THW N/A
- TRDA N/A
- Revenue Next Year
- THW N/A
- TRDA N/A
- P/E Ratio
- THW N/A
- TRDA $14.14
- Revenue Growth
- THW N/A
- TRDA 5.74
- 52 Week Low
- THW $9.76
- TRDA $7.10
- 52 Week High
- THW $14.89
- TRDA $21.79
- Technical
- Relative Strength Index (RSI)
- THW 44.06
- TRDA 50.56
- Support Level
- THW $10.51
- TRDA $7.71
- Resistance Level
- THW $10.98
- TRDA $9.46
- Average True Range (ATR)
- THW 0.16
- TRDA 0.58
- MACD
- THW 0.03
- TRDA 0.09
- Stochastic Oscillator
- THW 40.00
- TRDA 69.71
About THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies engaged in the healthcare industry. The company's investment portfolio comprises investments in different sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other areas. It also male into REIT Real Estate.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.